UK markets closed

Xilio Therapeutics, Inc. (XLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1800-0.0800 (-6.35%)
At close: 04:00PM EDT
1.1896 +0.01 (+0.81%)
After hours: 07:25PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.11-0.48-1.47-0.96
Low estimate-0.69-0.6-2.16-1.89
High estimate0.47-0.36-0.79-0.04
Year ago EPS-0.83-0.7-2.78-1.47
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1122
Avg. Estimate30MN/A15M37.5M
Low estimate30MN/AN/AN/A
High estimate30MN/A30M75M
Year ago salesN/AN/AN/A15M
Sales growth (year/est)N/AN/AN/A150.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.89-0.87-0.81-0.64
Actual EPS-0.83-0.7-0.61-0.64
Difference0.060.170.20
Surprise %6.70%19.50%24.70%0.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.11-0.48-1.47-0.96
7 days ago-0.11-0.48-1.47-0.96
30 days ago-0.28-0.5-1.81-1.31
60 days ago-0.82-0.63-3.1-2.55
90 days ago-0.82-0.63-3.1-2.55
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXLOIndustrySector(s)S&P 500
Current qtr.86.70%N/AN/AN/A
Next qtr.31.40%N/AN/AN/A
Current year47.10%N/AN/AN/A
Next year34.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A